TRAINING PATIENTS TO MANAGE THEIR TREATMENT EXPERIENCE
At-Home Maintenance: Subcutaneous Every 8 Weeks1
DOSING CONSIDERATIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional. Patients may self-inject SKYRIZI after training in use of the OBI. Provide proper training to patients and/or caregivers on the use of the OBI of SKYRIZI according to the Instructions for Use.1
Find patient support materials on dosing
Reference: 1. SKYRIZI [Summary of Product Characteristics]. Ludwigshafen, Germany: AbbVie Deutschland GmbH & Co; 2023.